dr_adam_edwards's profile picture. Stroke Research Group | Perron Institue Postdoctoral researcher investigating therapies for perinatal brain injury

Adam Edwards

@dr_adam_edwards

Stroke Research Group | Perron Institue Postdoctoral researcher investigating therapies for perinatal brain injury

New publication alert!

Updates on neonatal cell and novel therapeutics: Proceedings of the Second Neonatal Cell Therapies Symposium (2024) nature.com/articles/s4139… @Ped_Research @Neo_CellTherapy

Atul_Monash's tweet image. Updates on neonatal cell and novel therapeutics: Proceedings of the Second Neonatal Cell Therapies Symposium (2024)
nature.com/articles/s4139…

@Ped_Research @Neo_CellTherapy


Looking forward to an exciting and informative meeting. Get your abstracts in by the 10th of June!

The final program of the 2024 @Neo_CellTherapy Symposium #NCT2024 is out. See below 👇🏽 Thank you to all the stellar speakers and chairpersons. Abstract deadline 10th June. More info and registration: nct2024.eventbrite.com

Atul_Monash's tweet image. The final program of the 2024 @Neo_CellTherapy Symposium #NCT2024 is out. See below 👇🏽

Thank you to all the stellar speakers and chairpersons.

Abstract deadline 10th June.

More info and registration: nct2024.eventbrite.com
Atul_Monash's tweet image. The final program of the 2024 @Neo_CellTherapy Symposium #NCT2024 is out. See below 👇🏽

Thank you to all the stellar speakers and chairpersons.

Abstract deadline 10th June.

More info and registration: nct2024.eventbrite.com


Adam Edwards reposted

Today, #AGN attracted national media attention with the launch of its Phase 2 clinical trial of #ARG007 in stroke patients across Australia Here's a behind the scenes look at the media coverage at the launch. We look forward to sharing more in coming days...

ArgenicaT's tweet image. Today, #AGN attracted national media attention with the launch of its Phase 2 clinical trial of #ARG007 in stroke patients across Australia

Here's a behind the scenes look at the media coverage at the launch.  We look forward to sharing more in coming days...
ArgenicaT's tweet image. Today, #AGN attracted national media attention with the launch of its Phase 2 clinical trial of #ARG007 in stroke patients across Australia

Here's a behind the scenes look at the media coverage at the launch.  We look forward to sharing more in coming days...
ArgenicaT's tweet image. Today, #AGN attracted national media attention with the launch of its Phase 2 clinical trial of #ARG007 in stroke patients across Australia

Here's a behind the scenes look at the media coverage at the launch.  We look forward to sharing more in coming days...

Adam Edwards reposted

Agenda for the 2nd Neonatal Cell Therapies Symposium is almost finalised. 📅 June 24-25 2024 📌 @CPAllianceAU, Sydney, NSW Check out the program, submit an abstract & register ➡️ nct2024.eventbrite.com

Atul_Monash's tweet image. Agenda for the 2nd Neonatal Cell Therapies Symposium is almost finalised. 

 📅 June 24-25 2024
📌 @CPAllianceAU, Sydney, NSW

Check out the program, submit an abstract & register ➡️
nct2024.eventbrite.com


Amazing news and a fantastic team effort!

ASX ANNOUNCEMENT // Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) status to ARG-007 for the treatment of Hypoxic Ischaemic Encephalopathy (HIE). Read the full announcement here: bit.ly/3EgFuDN #ASX #AGN #ARG007 #FDA #HIE

ArgenicaT's tweet image. ASX ANNOUNCEMENT // 

Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) status to ARG-007 for the treatment of Hypoxic Ischaemic Encephalopathy (HIE).

Read the full announcement here: bit.ly/3EgFuDN

#ASX #AGN #ARG007 #FDA #HIE


I am grateful to @BetsyPilon and the @HopeforHIE family for becoming a crucial part of the multidisciplinary team to find a treatment for HIE! #neoTwitter #HIEAwarenessMonth #neurotwitter #AGN

We are excited to announce our support and partnership with @HopeforHIE, a global patient advocacy and support organisation, during April’s HIE Awareness month! Learn more: bit.ly/3MTQcqk #AGN #HIE #HopeforHIE #HIEAwarenessMonth



A fantastic initiative! I hope this seeds the ripple of a move towards non-for-profit publishing across academia.

All NeuroImage and NeuroImage:Reports editors have resigned over the high publication fee, and are starting a new non-profit journal imaging-neuroscience.org This comes with great regret, and a huge amount of thought and discussion- please read announcement to get more details.

ImagingNeurosci's tweet image. All NeuroImage and NeuroImage:Reports editors have resigned over the high publication fee, and are starting a new non-profit journal

imaging-neuroscience.org

This comes with great regret, and a huge amount of thought and discussion- please read announcement to get more details.
ImagingNeurosci's tweet image. All NeuroImage and NeuroImage:Reports editors have resigned over the high publication fee, and are starting a new non-profit journal

imaging-neuroscience.org

This comes with great regret, and a huge amount of thought and discussion- please read announcement to get more details.


Adam Edwards reposted

AGN recently welcomed @dr_adam_edwards onto our management team as our Neonatal Scientific & Regulatory Advisor. Learn more about Dr Edwards here: bit.ly/3TbmcaJ #HIE #AGN $AGN #clinicalresearch #biotech

ArgenicaT's tweet image. AGN recently welcomed @dr_adam_edwards onto our management team as our Neonatal Scientific & Regulatory Advisor. 

Learn more about Dr Edwards here: bit.ly/3TbmcaJ #HIE #AGN $AGN #clinicalresearch #biotech

An invaluable study highlighting the importance of long-term clinical follow-up for hypothermia treated infants with HIE. Stresses the importance of improved clinical trial outcome measures for emerging therapeutics!

Delighted to share our latest publication on long-term outcome in children with a history of hypothermia-treated HIE. Renewed assessment at 10-12 years revealed emerging deficits in 26% of children with previously favourable outcome at early school-age. fn.bmj.com/content/early/…



Adam Edwards reposted

Does Epo help in any neonatal brain injury? Short-term outcomes of EpoRepair trial out in @JAMANetworkOpen jamanetwork.com/journals/jaman… Erythropoietin in preterm infants with IVH did not improve brain injury scores at TEA & may increase mortality. #neoTwitter @EBNEO @ESPR_EBN

Atul_Monash's tweet image. Does Epo help in any neonatal brain injury? 

Short-term outcomes of EpoRepair trial out in @JAMANetworkOpen 
jamanetwork.com/journals/jaman…

Erythropoietin in preterm infants with IVH did not improve brain  injury scores at TEA & may increase mortality.

#neoTwitter @EBNEO @ESPR_EBN

Adam Edwards reposted

The era of automated home cage maternal behavior is here! Using @DeepLabCut and SimBA @GoldenNeuron, we generated models to track rat dams and pups and score seven maternal behaviors with high accuracy. 🧵


Adam Edwards reposted

The first clinical trial is underway for a novel neuroprotective drug to reduce brain tissue death after ischemic stroke. Commercialised by @ArgenicaT, ARG-007 was developed by Profs Bruno Meloni, Neville Knuckey and team at Perron Institute and @uwanews. ow.ly/XinE50LjMNh

PerronInstitute's tweet image. The first clinical trial is underway for a novel neuroprotective drug to reduce brain tissue death after ischemic stroke. Commercialised by @ArgenicaT, ARG-007 was developed by Profs Bruno Meloni, Neville Knuckey and team at Perron Institute and @uwanews. ow.ly/XinE50LjMNh

Adam Edwards reposted

A human brain can understand a supercomputer, but can a supercomputer understand a human brain? Researchers at the Perron Institute look forward to working with the supercomputing powers at @Team_DUG to understand our amazing brain.

PerronInstitute's tweet image. A human brain can understand a supercomputer, but can a supercomputer understand a human brain? Researchers at the Perron Institute look forward to working with the supercomputing powers at @Team_DUG to understand our amazing brain.

Adam Edwards reposted

The Nobel Prize in Physiology or Medicine has just been awarded to Swedish geneticist Svante Pääbo

Nature's tweet image. The Nobel Prize in Physiology or Medicine has just been awarded to Swedish geneticist Svante Pääbo

Adam Edwards reposted

This morning, Argenica Therapeutics is pleased to announce the Company’s ethics application to Bellberry’s HREC to commence a Phase 1 healthy participant study of ARG-007 has been APPROVED. Learn more here: bit.ly/36MeCzr #ASX #AGN #clinicaltrials #stroke #ARG007

ArgenicaT's tweet image. This morning, Argenica Therapeutics is pleased to announce the Company’s ethics application to Bellberry’s HREC to commence a Phase 1 healthy participant study of ARG-007 has been APPROVED.

Learn more here: bit.ly/36MeCzr

#ASX #AGN #clinicaltrials #stroke #ARG007

Adam Edwards reposted

This morning Argenica Therapeutics is pleased to announce the submission of the Company’s ethics application to Bellberry’s Human Research Ethics Committee (HREC) seeking approval to commence a Phase 1 healthy participant study of ARG-007. Read here: bit.ly/3vSDxLe

ArgenicaT's tweet image. This morning Argenica Therapeutics is pleased to announce the submission of the Company’s ethics application to Bellberry’s Human Research Ethics Committee (HREC) seeking approval to commence a Phase 1 healthy participant study of ARG-007.

Read here: bit.ly/3vSDxLe

Adam Edwards reposted

Dr Adam Edwards, postdoctoral researcher at Perron Institute discusses his work on hypoxic ischaemic encephalopathy (HIE) in today's @westaustralian and the hope the ARG-007 drug being developed via @ArgenicaT and @uwanews will improve quality of life.

PerronInstitute's tweet image. Dr Adam Edwards, postdoctoral researcher at Perron Institute discusses his work on hypoxic ischaemic encephalopathy (HIE) in today's @westaustralian and the hope the ARG-007 drug being developed via @ArgenicaT and @uwanews will improve quality of life.
PerronInstitute's tweet image. Dr Adam Edwards, postdoctoral researcher at Perron Institute discusses his work on hypoxic ischaemic encephalopathy (HIE) in today's @westaustralian and the hope the ARG-007 drug being developed via @ArgenicaT and @uwanews will improve quality of life.

United States Trends

Loading...

Something went wrong.


Something went wrong.